| |
|
|
|
Oxford Global, Cambridge, MA, USA
01-02 November 2023
Oxford Global is pleased to share with you the programme of Drug Discovery US, coming to the heart of Cambridge, Boston in November. Providing a unique opportunity to maximise your event experience you will have the chance to participate in engaging discussions and meetings by delving into some of the most prevalent areas of the industry: emerging modalities in target identification and validation, fragment and structure-based drug design, medicinal chemistry, bioengineering, tissue chip and organ modelling development and applications. We look forward to seeing you there!
|
|
|
|
|
|
|
|
Organized by:
|
|
Oxford Global |
|
|
Invited Speakers:
|
|
- MARK MURCKO | Director, Dewpoint Therapeutics
- DANE CORNEIL | Director of AI Science, BenevolentAI
- BETH HOFFMAN | Chief Executive Officer, Origami Therapeutics
- THOMAS NITTOLI | Senior Director, Regeneron Pharmaceuticals, Inc
- SHAHAR KEINAN | Chief Executive Officer, Polaris Quantum Biotech
- MATTHEW PHARRIS | Senior Scientist, UCB
- JOHN SANTA MARIA | Associate Director, Fog Pharmaceuticals
- ERIC MIELE | Associate Director, AstraZeneca
- SHAUN MCLOUGHLIN | Principal Research Scientist, AbbVie
- ISTVAN ENYEDY | Senior Director, Theseus Pharmaceuticals
- JONATHAN PROTO | Principal Scientist, Sanofi
- LAUREN GOODRICH | Vice President, Therapeutic Discovery, Nimble Therapeutics
- HASAN KHAN | Senior Scientist, AbbVie
- JEFF MESSER | Director, GSK
- EMMANUEL BENGIO | Senior Machine Learning Scientist, Recursion Pharmaceuticals
- YUXIN LIANG | Principal Scientific Manager, Genentech
- JAMES HICKMAN | Professor, Nanoscience Technology Center, University of Central Florida
- ERIC MARTIN | Director, Computational Chemistry, Novartis
- CHRIS TAME | Director, Benevolent AI
- XIANG CHEN | Associate Member, St Jude Children’s Research Hospital
- PETRINA KAMYA | Head of AI Platform, Insilico Medicine
- YUAN WANG | Head, Research Analytics, UCB
- NILS JAKOB HANSEN | Chief Executive Officer, Vipergen ApS
- MAXIMILIAN SCHUIER | Senior Global Medical Affairs Leader Neuropsychiatry, Janssen
- BRADLEY MORGAN | Senior Vice President, Cytokinetics
- STEFAN PEUKERT | Associate Director, Novartis
- MIKE SCHOPPERLE | Chief Executive Officer, CureMeta
- PAUL SCOLA | Group Director, Bristol Myers Squibb
- CHRISTOPHER BARBIERI | Associate Director, Bristol Myers Squibb
- MARTIN REDHEAD | Executive Director Primary Pharmacology, Exscientia
- TIM AHFELDT | Vice President of Advanced Translational Modelling, Recursion Pharmaceuticals
- ANGEL GUZMAN-PEREZ | Head of Chemistry, Scorpion Therapeutics
- JEANNIE LEE | Professor of Genetics, Harvard Medical School
- ELLIOTT NICKBARG | Principal Scientist, Merck
- JOHN QUINN | Distinguished Scientist and Head of SPR-Biophysics, Genentech
- RALPH MAZITSCHEK | Investigator, Harvard Medical School
- THOMAS HARTUNG | Professor and Chair, John Hopkins University
- HONGWU WANG | Principal Scientist, Merck & Co., Inc
- SURESH KUMAR | Vice President R&D, Progenra
- AARON FRANK | Director and Head of Computational Chemistry, Arrakis Therapeutics
- SINA MOHAMMADI | Principal Scientist, Merck
- TOMEK CIERPICKI | Professor, University of Michigan
- DAVE MAUGER | Director of Data Science, Arrakis Therapeutics
- TOBIAS RAABE | Research Assistant Professor, University of Pennsylvania
- ABHINAV SHARMA | Senior Scientist, AbbVie
- ESTHER LEE | Associate Director, AstraZeneca
- KEVIN ROBBINS | Associate Principal Scientist, AstraZeneca
- RAJESWARI BASU | Research Scientist, Boehringer Ingelheim
- BANU PRIYA SRIDHARAN | Associate Director, GSK
- JOE FRANKLIN | Senior Vice President, Anagenex
- GISELE NISHIGUCHI | Group Leader, St Jude Children’s Hospital
- RUBEN ABAGYAN | Professor, University of California
- INDIA OTT | Research Scientist, AstraZeneca
- LUCAS MASTROMATTEO | Data Analyst, GSK
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
01 November 2023
|
|
|
|
|
|
|
|
Registration:
|
|
https://www.oxfordglobal.co.uk/discovery-us/book-now/
|
|
|
E-mail:
|
|
m.blakey@oxfordglobal.co.uk
|
|
|
|
|
|
|
|
|